Loomis Sayles & CO L P Novo Nordisk A S Transaction History
Loomis Sayles & CO L P
- $69.2 Billion
- Q1 2025
A detailed history of Loomis Sayles & CO L P transactions in Novo Nordisk A S stock. As of the latest transaction made, Loomis Sayles & CO L P holds 12,388,242 shares of NVO stock, worth $827 Million. This represents 1.24% of its overall portfolio holdings.
Number of Shares
12,388,242
Previous 11,571,686
7.06%
Holding current value
$827 Million
Previous $995 Million
13.58%
% of portfolio
1.24%
Previous 1.26%
Shares
32 transactions
Others Institutions Holding NVO
# of Institutions
1,763Shares Held
340MCall Options Held
11.4MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.26 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$988 Million0.08% of portfolio
-
Morgan Stanley New York, NY12.3MShares$823 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$793 Million0.36% of portfolio
-
Fayez Sarofim & CO Houston, TX11.2MShares$749 Million2.01% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $151B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...